TYROSINASE-CATALYZED BINDING OF 3,4-DIHYDROXYPHENYLALANINE WITH PROTEINS THROUGH THE SULFHYDRYL-GROUP

被引:78
作者
KATO, T
ITO, S
FUJITA, K
机构
[1] FUJITA GAKUEN HLTH UNIV, SCH HYG, TOYOAKE, AICHI 47011, JAPAN
[2] FUJITA GAKUEN HLTH UNIV, SCH MED, INST COMPREHENS MED SCI, TOYOAKE, AICHI 47011, JAPAN
关键词
D O I
10.1016/0304-4165(86)90034-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytotoxicity of catechols has been ascribed to covalent binding of the o-quinone oxidation products to proteins through sulfhydryl groups. The nature of the covalent binding was studied with dopaquinone formed on tyrosinase oxidation of 3,4-dihydroxyphenylalanine (DOPA). After acid hydrolysis of the reaction products, cysteinyldopas liberated (protein-bound cysteinyldopas) were determined by HPLC with electrochemical detection. When 0.1 mM DOPA was oxidized in the presence of 0.2 mM bovine serum albumin, alcohol dehydrogenase or isocitrate dehydrogenase, protein-bound cysteinyldopas were formed in yields of 5.4, 44, or 33%, respectively. The covalent binding was almost completely inhibited by 1 mM cysteine or 1 mM ascorbic acid, but 10 mM lysine had no effect. These results unambiguously demonstrate that dopaquinone can bind with proteins mostly through sulfhydryl groups.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 29 条
[1]  
CHELMICKASCHORR E, 1983, CANCER RES, V43, P3504
[2]   ROLE OF SULFHYDRYL GROUPS IN CATALYTIC FUNCTION OF ISOCITRATE DEHYDROGENASE .I. REACTION WITH 5,5'-DITHIOBIS(2-NITROBENZOIC ACID) [J].
COLMAN, RF .
BIOCHEMISTRY, 1969, 8 (03) :888-&
[3]  
DYBING E, 1976, MOL PHARMACOL, V12, P911
[4]  
FUJITA K, 1980, CANCER RES, V40, P2543
[5]   TOXICITY OF MELANIN PRECURSORS [J].
GRAHAM, DG ;
TIFFANY, SM ;
VOGEL, FS .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1978, 70 (02) :113-116
[6]  
GRAHAM DG, 1978, MOL PHARMACOL, V14, P633
[7]  
GRAHAM DG, 1978, MOL PHARMACOL, V14, P644
[9]   SYNTHESIS AND ANTI-TUMOR ACTIVITY OF CYSTEINYL-3,4-DIHYDROXYPHENYLALANINES AND RELATED-COMPOUNDS [J].
ITO, S ;
INOUE, S ;
YAMAMOTO, Y ;
FUJITA, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (06) :673-677
[10]  
ITO S, 1982, BIOCHEM PHARMACOL, V31, P2887